Vivera Pharmaceuticals, Inc. — Form D
Vivera Pharmaceuticals, Inc. of NEWPORT BEACH, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-10. The offering totals $3.0M, of which $1.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-09-10
- Form: D
- Accession: 0001751371-18-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.1M
- Remaining: $1.9M
- Investors: 8
- Date of first sale: 2018-05-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-320915
Issuer
- Name: Vivera Pharmaceuticals, Inc.
- CIK: 0001751371
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 4533 MACARTHUR BOULEVARD #5049, NEWPORT BEACH, CA, 92660
- Phone: 844-484-8372
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Paul Edalat | Director | Newport Beach, CA |
| Paul Edalat | Executive Officer | Newport Beach, CA |
More